Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Bermejo, I. orcid.org/0000-0001-9105-8088, Stevenson, M. orcid.org/0000-0002-3099-9877, Cooper, K. orcid.org/0000-0002-7702-8103 et al. (6 more authors) (2017) Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. ISSN 1170-7690

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 Adis. This is an author produced version of a paper subsequently published in PharmacoEconomics. Uploaded in accordance with the publisher's self-archiving policy. The final publication is available at Springer via https://doi.org/10.1007/s40273-017-0571-8.
Dates:
  • Published (online): 20 September 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Funding Information:
FunderGrant number
NATIONAL INSTITUTE FOR HEALTH RESEARCH14/25/02
Depositing User: Symplectic Sheffield
Date Deposited: 02 Oct 2017 08:37
Last Modified: 20 Sep 2018 00:38
Published Version: https://doi.org/10.1007/s40273-017-0571-8
Status: Published online
Publisher: Adis
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-017-0571-8
Related URLs:

Share / Export

Statistics